582 Companies
Late-stage clinical biopharmaceutical company, X4 Pharmaceuticals, is dedicated to the development and commercialization of innovative therapeutics aimed at treating rare diseases. The company's pr...
X4 Pharmaceuticals Annual Report 2023Bluebird bio, Inc., a renowned biotechnology company, has been actively engaged in researching, developing, and commercializing gene therapies meant for severe genetic diseases. Its diverse range o...
bluebird bio Annual Report 2021Monmouth Junction-based Ayala Pharmaceuticals, Inc. is making significant strides in the field of oncology, focusing on the development and commercialization of small molecule therapeutics for peop...
Advaxis Inc. Annual Report 2020Dicerna Pharmaceuticals is a US-based biopharmaceutical company that specializes in developing treatments for liver diseases and cancers using their proprietary RNA interference technology platform...
Dicerna Pharmaceuticals Annual Report 2019Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, is making strides in the development and commercialization of therapeutics to transform radiotherapy in cancer patients. The P...
Galera Therapeutics, Inc. Annual Report 2023Celldex Therapeutics, Inc., a biopharmaceutical company, is striving to develop therapeutic monoclonal and bispecific antibodies for numerous diseases, including inflammatory diseases and various f...
Celldex Therapeutics Inc. Annual Report 2023Otonomy is a clinical-stage biopharmaceutical company that develops and commercializes therapeutics for ear diseases and disorders in the US and Canada. Its lead product candidate, AuriPro, complet...
Otonomy Annual Report 2020Spring Bank Pharmaceuticals is a clinical-stage biopharmaceutical company that specializes in discovering and developing therapeutics using its small molecule nucleic acid hybrid (SMNH) chemistry p...
Spring Bank Pharmaceuticals, Inc. Annual Report 2018Kala Pharmaceuticals, Inc. announced today that it is dedicated to finding and developing new treatments for eye diseases. Its commitment to this mission is reflected in its extensive product pipel...
Kala Pharmaceuticals Annual Report 2023Kaleido Biosciences, Inc., a healthcare company in its clinical-stage, is positioning itself as a player in the microbiome metabolic therapies arena. The company’s development pipeline includes tre...
Kaleido Biosciences, Inc. Annual Report 2020Novato-based biopharmaceutical company Ultragenyx Pharmaceutical Inc. is dedicated to developing and distributing new products to treat rare and ultra-rare genetic diseases around the world. Its bi...
Ultragenyx Pharmaceutical Annual Report 2023Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company that has set its sights on the discovery, development, and commercialization of medications for treating serious central n...
Cyclerion Therapeutics, Inc. Annual Report 2023Five Prime Therapeutics is a biotechnology company that aims to develop protein therapeutics for treating cancer and inflammatory diseases. Its leading product candidate, FPA008, is an antibody tha...
Five Prime Therapeutics Inc Annual Report 2018Sirtex Medical Limited is a global pharmaceutical company that specializes in developing and distributing oncology treatments using small particle technology. With a focus on the Asia Pacific, Nort...
Sirtex Medical Limited Annual Report 2017Noxopharm is a clinical-stage drug development company focused on creating treatments for various types of solid tumor cancers and septic shock. The company's pipeline drug candidate, Veyonda, is c...
Noxopharm Annual Report 2023